Lamivudine use in pregnant HBsAg-females effectively reduces maternal viremia
ConclusionThe use of lamivudine during pregnancy can effectively lower maternal viral load. Timely conducted post-vaccination serological testing is crucial to detect positive cases and immunize susceptible infants.
Source: Arab Journal of Gastroenterology - Category: Gastroenterology Source Type: research
More News: Gastroenterology | Hepatitis | Hepatitis B | Hepatitis Vaccine | Middle East Health | Pregnancy | Study | Vaccines | Women